✦ LIBER ✦

Summary of phase II clinical and laboratory safety experience with Entecavir

✍ Scribed by E.R. Schiff; R. Hindes; A. O'Donnell; D. DeHertogh; B. Kreter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of entecavir in nucl

✍ Haruhiko Kobashi; Kouichi Takaguchi; Hiroshi Ikeda; Osamu Yokosuka; Mitsuhiko Mo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

498 Efficacy and safety of entecavir in

✍ Y. Karino; J. Toyota; H. Kumada; Y. Katano; N. Izumi; Y. Shiratori; M. Sata; T. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Clinical efficacy and safety of cerivast

✍ Jean Davignon; Markolf Hanefeld; Noriaki Nakaya; Donald B Hunninghake; William I 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 590 KB

The safety of efalizumab in patients wit

✍ Craig Leonardi; Bernard Goffe; Jeff Sobell; Ivor Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Clinical Experience with Tilavist: An Ov

✍ N-I Max Kjellman; Michael T Stevens 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

The ustekinumab safety experience in pat

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB